Acorda Therapeutics Inc. (ACOR) Declined -14.81% or -4.25 To Price $24.45 On Wednesday


Acorda Therapeutics Inc. (ACOR) declined -14.81% or -4.25 to $24.45. It is close to 1.91 million shares traded, which is 332.95% compare to the average total volume 574829. The market cap of ACOR is $1.15 billion. The year to date change is 11.9%. The 52 week price range is from $16.55 to $36.35. Price of ACOR have changed 0.00% during last week. It have changed -0.52% over last month, 22.91% over last 3 months, 3.24% over last 6 months and 28.13% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ACOR is 27.99. It is 14.48% above current price. The 200-day Moving Averages for ACOR is 25.09. It is 2.62% above current price. The 52-week High is 36.35. It is 48.67% from the current price. The 52-week Low is 16.55. It is -32.31% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ACOR is 5.43 on 2018-06-29. Short % to float is 10.78%. There are some statistics of ACOR. It is has market cap $1.15 billion. The share outstanding is 47.07 million. The average volume is 574829. The revenue is 468.90M. It has 333.63M cash and 996.05M in debt. The gross profit is 358.53M. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ACOR is -34.69%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ACOR is -16.97%.


Tags:

Share this post